Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | The future of ambulatory care in the treatment of hematological conditions and malignancies

Amy Colada • 29 Apr 2024
BSH 2024
General Antibodies CAR-T

Amy Colada, University College London Hospital, London, UK, briefly discusses her views on the future role of ambulatory care in the treatment of non-malignant hematological conditions and hematological malignancies. As the number of patients receiving novel treatments grows, there will be a significant challenge with capacity in the inpatient setting, and more ambulatory care units will be set up to treat these individuals. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Amy Colada

2:00
The effectiveness of ambulatory care for patients undergoing stem cell transplantation
Amy Colada • 29 Apr 2024

Related Videos

4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
1:56
Addressing access inequality in CAR-T therapies
Francesca Del Bufalo • 15 Apr 2024
1:34
The future role of AI models in hematology and the need for high-quality data sets
Thomas Coats • 29 Apr 2024
6:38
Key papers in cardio-oncology from 2023 of relevance to hematologists
Alexander Lyon • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals